JBIO
Jade Biosciences, Inc. Common Stock
JBIO
JBIO
75 hedge funds and large institutions have $315M invested in Jade Biosciences, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 4 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
27
Increased
40
Reduced
4
Closed
30
Calls
–
Puts
$1.52M
Net Calls
-$1.52M
Net Calls Change
-$1.44M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.3M |
| 2 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$32.2M |
| 3 |
VA
VR Adviser
New York
|
+$32.2M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$25.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.8M |
Top Sellers
| 1 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$4.52M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$3.67M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$3.62M |
| 4 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$3.57M |
| 5 |
Blackstone Inc
New York
|
-$2.4M |
